Research Use Only. Products are not for human consumption, clinical use, or veterinary administration. RUO policy
5 mg
CoA on request
RUO
Metabolic Research

Semaglutide

Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.

Research price
$129
5 mg vial - Lyophilized powder
Research Use Only. This material is not for human consumption, injection, clinical use, or veterinary administration. Sold only to qualified researchers and institutions. RUO policy.

Lot documentation (CoA)

Request a lot-matched Certificate of Analysis for this research material when available. We do not host fabricated PDFs or publish invented purity statistics on product pages.

Specifications
Size5 mg
FormLyophilized powder
Purity / documentationLot-specific Certificate of Analysis provided on request when available via the Vial Vault. No instant site-wide purity claims.
CAS910463-68-2
Molecular weight4113.6 g/mol (reference)
Sequence / identityGLP-1 receptor agonist peptide analog (research material)
Intended useIn vitro laboratory research only (RUO)

Research context

Semaglutide research material is intended for laboratory investigation of GLP-1 receptor pathways and metabolic signaling in experimental systems. Not for human use. Use only in qualified research settings with appropriate institutional controls.

Research focus areas
GLP-1 pathway research Metabolic models Incretin signaling

Content is for scientific reference only and does not constitute medical advice or instructions for human use.

Continue your research workflow

Move from catalog specs to literature context, documentation, and lab planning tools. Research use only.

Related research materials

5 mg
CoA on request
Metabolic Research

Tirzepatide

Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.

$149
View
5 mg
CoA on request
Metabolic Research

Retatrutide

Investigational triple-agonist peptide for laboratory metabolic pathway research in model systems.

$179
View